The Known Immunologically Active Components of Astragalus Account for Only a Small Proportion of the Immunological Adjuvant Activity When Combined with Conjugate Vaccines

Abstract

The 95 % ethanol extract of Astragalus has been demonstrated to have potent activity as an immunological adjuvant when administered with vaccines of various types. We endeavor here to identify the components of this extract that are responsible for this adjuvant activity. Mice were immunized with KLH conjugated to cancer carbohydrate antigens globo H and GD3 and cancer peptide antigen MUC1 combined with different Astragalus fractions or with commercially available Astragalus saponins and flavonoids. The antibody responses against cancer antigens and KLH were quantitated in ELISA assays, and toxicity was calculated by weight loss. Astragalosides II and IV were the most active components, but the toxicity of these two differed dramatically. Astragaloside II was the most toxic Astragalus component with 5–10 % weight loss at a dose of 500 µg while astragaloside IV showed no weight loss at all at this dose, suggesting that astragaloside IV might be utilized as an immunological adjuvant in future studies. Several flavonoids also had significant adjuvant activity. However, when the activities of these known immunologically active components of Astragalus (and of endotoxin) are calculated based on the extent of their presence in the 95 % ethanol extract, they provide only a small proportion of the immunological activity. This raises the possibility that additional uniquely active components of Astragalus may contribute to adjuvant activity, or that the adjuvant activity of Astragalus is greater than the activity of the sum of its parts.

Key words

Astragalus membranaceus - Leguminosae - botanicals - conjugate vaccine - cancer vaccine - astragalosides - saponin

References

• 1 Ragupathi G, Park T K, Zhang S, Kim I J, Graeber K, Adluri S, Lloyd K O, Danishefsky S J, Livingston P O. Immunization of mice with the synthetic hexasaccharide Globo H results in antibodies against human cancer cells.  Angew Chem Int Ed Engl. 1997;  36 125-128
• 2 Kim S K, Ragupathi G, Cappello S, Kagan E, Livingston P O. Effect of immunological adjuvant combinations on the antibody and T-cell response to vaccination with MUC1-KLH and GD3-KLH conjugates.  Vaccine. 2000;  19 530-537
• 3 Ragupathi G, Yeung K S, Leung P C, Lee M, Lau C B, Vickers A, Hood C, Deng G, Cheung N K, Cassileth B, Livingston P. Evaluation of widely consumed botanicals as immunological adjuvants.  Vaccine. 2008;  26 4860-4865
• 4 Ross G D, Vetvicka V, Yan J, Xia Y, Vetvickova J. Therapeutic intervention with complement and beta-glucan in cancer.  Immunopharmacology. 1999;  42 61-74
• 5 [No authors listed]. Astragalus membranaceus. Monograph.  Altern Med Rev. 2003;  8 72-77
• 6 Chu K K, Ho S S, Chow A H. Coriolus versicolor: a medicinal mushroom with promising immunotherapeutic values.  J Clin Pharmacol. 2002;  42 976-984
• 7 Spellman K, Burns J, Nichols D, Winters N, Ottersberg S, Tenborg M. Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators.  Altern Med Rev. 2006;  11 128-150
• 8 Kamiyama H, Takano S, Ishikawa E, Tsuboi K, Matsumura A. Anti-angiogenic and immunomodulatory effect of the herbal medicine “Juzen-taiho-to” on malignant glioma.  Biol Pharm Bull. 2005;  28 2111-2116
• 9 Matsumoto T, Sakurai M H, Kiyohara H, Yamada H. Orally administered decoction of Kampo (Japanese herbal) medicine, “Juzen-Taiho-To” modulates cytokine secretion and induces NKT cells in mouse liver.  Immunopharmacology. 2000;  46 149-161
• 10 Kodama N, Komuta K, Nanba H. Can maitake MD-fraction aid cancer patients?.  Altern Med Rev. 2002;  7 236-239
• 11 Smith J E S R. Immunomodulatory activities of mushroom glucans and polysaccharide-protein complexes in animals and humans, Chapter 6. London; Cancer Res UK 2002: 106
• 12 Maheshwari R K, Singh A K, Gaddipati J, Srimal R C. Multiple biological activities of curcumin: a short review.  Life Sci. 2006;  78 2081-2087
• 13 Xiao W, Wang Q, Unachukwu U, Lau C B, Jiang B, Hong F, Leung P C, Motley T, Livingston P, Cassileth B, Kennelly E. Chemical and genetic assessment of commercial Radix Astragali (Astragalus spp.) by ion trap LC-MS and nuclear ribosomal DNA sequence analyses.  J Agric Food Chem. ;  , , in press
  
• 14 Ragupathi G, Cappello S, Yi S S, Canter D, Spassova M, Bornmann W G, Danishefsky S J, Livingston P O. Comparison of antibody titers after immunization with monovalent or tetravalent KLH conjugate vaccines.  Vaccine. 2002;  20 1030-1038
• 15 Ragupathi G, Meyers M, Adluri S, Howard L, Musselli C, Livingston P O. Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21.  Int J Cancer. 2000;  85 659-666
• 16 Gilewski T, Adluri S, Ragupathi G, Zhang S, Yao T J, Panageas K, Moynahan M, Houghton A, Norton L, Livingston P O. Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21.  Clin Cancer Res. 2000;  6 1693-1701
• 17 Kim S K, Ragupathi G, Musselli C, Choi S J, Park Y S, Livingston P O. Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugate cancer vaccines.  Vaccine. 1999;  18 597-603
• 18 Livingston P O, Adluri S, Helling F, Yao T J, Kensil C R, Newman M J, Marciani D. Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma.  Vaccine. 1994;  12 1275-1280
• 19 Chu D T, Wong W L, Mavligit G M. Immunotherapy with Chinese medicinal herbs. II. Reversal of cyclophosphamide-induced immune suppression by administration of fractionated Astragalus membranaceus in vivo.  J Clin Lab Immunol. 1988;  25 125-129
• 20 Sun H X, Qin F, Ye Y P. Relationship between haemolytic and adjuvant activity and structure of protopanaxadiol-type saponins from the roots of Panax notoginseng.  Vaccine. 2005;  23 5533-5542
• 21 Yang Z G, Sun H X, Fang W H. Haemolytic activities and adjuvant effect of Astragalus membranaceus saponins (AMS) on the immune responses to ovalbumin in mice.  Vaccine. 2005;  23 5196-5203
• 22 Leung A Y, Foster S. Encyclopedia of common natural ingredients used in food, drugs and cosmetics, 2nd edition. New York, NY; John Wiley & Sons 1996
• 23 Upton R S C. Astragalus root: Analytical, quality control, and therapeutic monograph. Scotts Valley; American Herbal Pharmacopoeia 1999: 1-25
• 24 Kim Y J, Wang P, Navarro-Villalobos M, Rohde B D, Derryberry J, Gin D Y. Synthetic studies of complex immunostimulants from Quillaja saponaria: synthesis of the potent clinical immunoadjuvant QS-21Aapi.  J Am Chem Soc. 2006;  128 11906-11915
• 25 Liu J, Hu X, Yang Q, Yu Z, Zhao Z, Yi T, Chen H. Comparison of the immunoregulatory function of different constituents in radix astragali and radix hedysari.  J Biomed Biotechnol. 2010;  2010 479426
• 26 Qi L W, Yu Q T, Li P, Li S L, Wang Y X, Sheng L H, Yi L. Quality evaluation of Radix Astragali through a simultaneous determination of six major active isoflavonoids and four main saponins by high-performance liquid chromatography coupled with diode array and evaporative light scattering detectors.  J Chromatogr A. 2006;  1134 162-169
• 27 Yu Q T, Qi L W, Li P, Yi L, Zhao J, Bi Z. Determination of seventeen main flavonoids and saponins in the medicinal plant Huang-qi (Radix astragali) by HPLC-DAD-ELSD.  J Sep Sci. 2007;  30 1292-1299